Sponsored by the US Department of Energy and in collaboration with Radiochemistry/Cyclotron Core Facility head Ronald Finn, I led an effort to develop novel radiopharmaceuticals for implementation in research in both animals and humans. During the past ten years, this effort has resulted in the introduction of more than 40 new radionuclides and compounds for implementation in animal research here at Memorial Sloan-Kettering.
Over the years, I have served on several government advisory committees. I chaired the Radioactive Drug Advisory Committee of the US Food and Drug Administration and was part of a team that developed the 21CFR361.1 Radioactive Drug Research Committee regulations. I am currently the principal investigator of several large grants from the DOE and the National Institutes of Health, including the grant that provides funding for Memorial Sloan Kettering's Center for Multidisciplinary In Vivo Molecular Imaging in Cancer.
I have received a number of awards in nuclear medicine, including the Hevesy Award from both the Society of Nuclear Medicine (SNM) and the European Society of Nuclear Medicine, the Pendergrass Award and the Radiologic Researcher of the Year Award from the Radiological Society of North America, and the Wagner Lecture Award from the SNM. I have also received the Wiley Medal from the FDA, for distinguished service.